+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cancer Pain Management Market - Global Forecast 2026-2032- Product Image
Cancer Pain Management Market - Global Forecast 2026-2032- Product Image
New

Cancer Pain Management Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 181 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5924846
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior decision-makers face mounting complexity in the cancer pain management market. Shifts in clinical requirements, purchasing channels, and patient expectations demand strategic agility and targeted solutions for portfolio resilience and competitive positioning.

Market Snapshot: Cancer Pain Management Market Growth

The Cancer Pain Management Market is demonstrating sustained growth, expanding from USD 8.35 billion in 2025 to USD 8.87 billion in 2026, with a steady CAGR of 6.41%. By 2032, the market is anticipated to achieve USD 12.91 billion. This trajectory is propelled by innovations in clinical protocols, regulatory engagement, and a shift toward patient-centric care delivery. These drivers are shaping clinical practice, catalyzing technology adoption, and influencing how companies approach distribution across treatment settings.

Cancer Pain Management Market: Scope & Segmentation

This report offers a thorough evaluation of the evolving landscape in the Cancer Pain Management Market, illuminating strategic developments, operational shifts, and noteworthy segment trends. The analysis provides comprehensive insight for leadership decision-making across core dimensions:

  • Drug Classes: Examines opioids, nonsteroidal anti-inflammatory drugs, and adjuvant analgesics, including anticonvulsants, antidepressants, corticosteroids, and local anesthetics, highlighting their roles in tailored regimens.
  • Routes of Administration: Reviews oral delivery options such as capsules, tablets, and solutions, along with parenteral (intramuscular, intravenous, subcutaneous), sublingual, and transdermal approaches, emphasizing application in various care settings.
  • Distribution Channels: Considers hospital and retail pharmacies as well as online pharmacies, assessing how product movement supports care provision in hospitals, cancer institutes, home care, and outpatient clinics.
  • End-User Settings: Identifies inpatient, outpatient, and remote or telehealth-enabled environments, focusing on strategies to individualize pain management and extend clinical reach.
  • Clinical Applications: Explores management of bone metastasis pain, neuropathic pain, and visceral pain, highlighting opportunities for flexible therapy combinations and personalization.
  • Regions: Covers the Americas, Europe, Middle East & Africa, and Asia-Pacific, each shaped by distinct infrastructure, payment models, and regulatory policies, influencing market potential and operational strategy.

Key Takeaways for Senior Decision-Makers

  • Adoption of integrated, patient-focused protocols is advancing standards in both clinical care and market positioning, leveraging diverse pain management techniques and combination therapies.
  • Physician leadership programs and novel analgesic modalities are shifting prescriber behavior, encouraging long-term adoption of innovative solutions while influencing therapeutic choices.
  • Technological advancements, especially in orally administered and non-invasive sustained-release formulations, are improving treatment adherence and patient experience, impacting both clinical and operational preferences.
  • Value-based contracts and results-oriented payer agreements are becoming more prevalent, guiding formulary decisions and bolstering outpatient care within complex health systems and oncology pathways.
  • Supply chain strategies and local distribution resilience are now critical priorities, as market participants respond to regulatory filings and regionalization by adapting sourcing and partnership approaches to mitigate operational risk.
  • Data from real-world practice, patient feedback, and hospital analytics are increasingly essential for substantiating product value and ensuring access across evolving care models.

Tariff Impact on Sourcing, Supply Chain, and Access

Tariff adjustments introduced in 2025 have intensified commercial pressures, necessitating nimble sourcing, manufacturing alignment, and pricing recalibration. Manufacturers are pursuing regionalization, diversifying logistics networks, and engaging in cross-functional risk planning to sustain access. Health systems, in turn, are prioritizing supply continuity and responsive procurement strategies that safeguard critical product lines against volatility and ensure patient care quality.

Methodology & Data Sources

The report’s findings stem from a layered methodology, integrating peer-reviewed clinical publications, regulatory guidance, stakeholder interviews, and supply chain analytics. Triangulating clinical, policy, and operational insights delivers an accurate reflection of sector dynamics and best-practice developments within the cancer pain management market.

Why This Report Matters in the Cancer Pain Management Market

  • Empowers executives to navigate and capitalize on shifts in regulation, clinical care models, and resource deployment, supporting more adaptive and informed decision-making.
  • Supports sustained product innovation and supply chain resilience by synthesizing insights from the full patient care continuum and linking evidence to actionable strategies.
  • Equips leadership teams with complete segmentation and in-depth regional analysis, facilitating discovery of growth pockets and competitive positioning risks.

Conclusion

Achieving strategic advantage in cancer pain management requires integrating clinical development, real-world evidence, and agile supply models. This alignment supports improved patient outcomes and organizational sustainability in increasingly complex global care environments.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Cancer Pain Management Market, by Drug Class
8.1. Adjuvant Analgesics
8.1.1. Anticonvulsants
8.1.2. Antidepressants
8.1.3. Corticosteroids
8.2. Local Anesthetics
8.3. Nsaids
8.4. Opioids
8.4.1. Natural
8.4.2. Semi-Synthetic
8.4.3. Synthetic
9. Cancer Pain Management Market, by Route Of Administration
9.1. Oral
9.1.1. Capsules
9.1.2. Solutions
9.1.3. Tablets
9.2. Parenteral
9.2.1. Intramuscular
9.2.2. Intravenous
9.2.3. Subcutaneous
9.3. Sublingual
9.3.1. Films
9.3.2. Lozenges
9.4. Transdermal
10. Cancer Pain Management Market, by Distribution Channel
10.1. Hospital Pharmacy
10.2. Online Pharmacy
10.3. Retail Pharmacy
11. Cancer Pain Management Market, by End User
11.1. Cancer Institutes
11.2. Home Care
11.3. Hospitals
12. Cancer Pain Management Market, by Application
12.1. Bone Metastasis Pain
12.2. Neuropathic Pain
12.3. Visceral Pain
13. Cancer Pain Management Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Cancer Pain Management Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Cancer Pain Management Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Cancer Pain Management Market
17. China Cancer Pain Management Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. AbbVie Inc.
18.7. Aegis Therapeutics, LLC
18.8. Aptinyx Inc.
18.9. Astellas Pharma Inc.
18.10. Bausch Health Companies Inc.
18.11. Baxter International Inc.
18.12. Bayer AG
18.13. Biogen Inc.
18.14. Boehringer Ingelheim International GmbH
18.15. Eisai Co., Ltd.
18.16. Eli Lilly and Company
18.17. Glaxosmithkline PLC
18.18. Grünenthal Group
18.19. Johnson & Johnson Services, Inc.
18.20. Merck & Co. Inc.
18.21. Novartis AG
18.22. Pfizer Inc.
18.23. Regeneron Pharmaceuticals Inc.
18.24. Sanofi SA
18.25. Scilex Pharmaceuticals
18.26. Teva Pharmaceutical Industries Ltd.
18.27. Trevena Inc.
List of Figures
FIGURE 1. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CANCER PAIN MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CANCER PAIN MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ANTICONVULSANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ANTICONVULSANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ANTICONVULSANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ANTIDEPRESSANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ANTIDEPRESSANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY CORTICOSTEROIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY CORTICOSTEROIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY NSAIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY NSAIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY NSAIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY NATURAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY NATURAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY NATURAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY SEMI-SYNTHETIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY SEMI-SYNTHETIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY SEMI-SYNTHETIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY SYNTHETIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY CAPSULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY TABLETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY TABLETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBCUTANEOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY FILMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY FILMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY FILMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY LOZENGES, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY LOZENGES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY LOZENGES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY TRANSDERMAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY TRANSDERMAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY CANCER INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY CANCER INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY CANCER INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY BONE METASTASIS PAIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY BONE METASTASIS PAIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY BONE METASTASIS PAIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY NEUROPATHIC PAIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY NEUROPATHIC PAIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY NEUROPATHIC PAIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY VISCERAL PAIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY VISCERAL PAIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY VISCERAL PAIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 138. LATIN AMERICA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2032 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 150. EUROPE CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. EUROPE CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 152. EUROPE CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2032 (USD MILLION)
TABLE 153. EUROPE CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
TABLE 154. EUROPE CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 155. EUROPE CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 156. EUROPE CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 157. EUROPE CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2032 (USD MILLION)
TABLE 158. EUROPE CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 159. EUROPE CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. EUROPE CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. MIDDLE EAST CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 163. MIDDLE EAST CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
TABLE 165. MIDDLE EAST CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 166. MIDDLE EAST CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 168. MIDDLE EAST CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2032 (USD MILLION)
TABLE 169. MIDDLE EAST CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 170. MIDDLE EAST CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 171. MIDDLE EAST CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 172. AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 173. AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 174. AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2032 (USD MILLION)
TABLE 175. AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
TABLE 176. AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 177. AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 178. AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 179. AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2032 (USD MILLION)
TABLE 180. AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 181. AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 182. AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 188. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 194. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 195. ASEAN CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 196. ASEAN CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 197. ASEAN CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2032 (USD MILLION)
TABLE 198. ASEAN CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
TABLE 199. ASEAN CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 200. ASEAN CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 201. ASEAN CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 202. ASEAN CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2032 (USD MILLION)
TABLE 203. ASEAN CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 204. ASEAN CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 205. ASEAN CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 206. GCC CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 207. GCC CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 208. GCC CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2032 (USD MILLION)
TABLE 209. GCC CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
TABLE 210. GCC CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 211. GCC CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 212. GCC CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 213. GCC CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2032 (USD MILLION)
TABLE 214. GCC CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 215. GCC CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 216. GCC CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 217. EUROPEAN UNION CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 218. EUROPEAN UNION CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 219. EUROPEAN UNION CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2032 (USD MILLION)
TABLE 220. EUROPEAN UNION CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
TABLE 221. EUROPEAN UNION CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 222. EUROPEAN UNION CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 223. EUROPEAN UNION CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 228. BRICS CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 229. BRICS CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 230. BRICS CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2032 (USD MILLION)
TABLE 231. BRICS CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
TABLE 232. BRICS CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 233. BRICS CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 234. BRICS CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 235. BRICS CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2032 (USD MILLION)
TABLE 236. BRICS CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 237. BRICS CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 238. BRICS CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 239. G7 CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 240. G7 CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 241. G7 CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2032 (USD MILLION)
TABLE 242. G7 CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
TABLE 243. G7 CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 244. G7 CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 245. G7 CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 246. G7 CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2032 (USD MILLION)
TABLE 247. G7 CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 248. G7 CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 249. G7 CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 250. NATO CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 251. NATO CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 252. NATO CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2032 (USD MILLION)
TABLE 253. NATO CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
TABLE 254. NATO CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 255. NATO CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 256. NATO CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 257. NATO CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2032 (USD MILLION)
TABLE 258. NATO CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 259. NATO CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 260. NATO CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 261. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 262. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 263. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 264. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2032 (USD MILLION)
TABLE 265. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
TABLE 266. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 267. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 268. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 269. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2032 (USD MILLION)
TABLE 270. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 271. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 272. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 273. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 274. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 275. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2032 (USD MILLION)
TABLE 276. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
TABLE 277. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 278. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 279. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 280. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2032 (USD MILLION)
TABLE 281. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 282. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 283. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Cancer Pain Management market report include:
  • Abbott Laboratories
  • AbbVie Inc.
  • Aegis Therapeutics, LLC
  • Aptinyx Inc.
  • Astellas Pharma Inc.
  • Bausch Health Companies Inc.
  • Baxter International Inc.
  • Bayer AG
  • Biogen Inc.
  • Boehringer Ingelheim International GmbH
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • Glaxosmithkline PLC
  • Grünenthal Group
  • Johnson & Johnson Services, Inc.
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals Inc.
  • Sanofi SA
  • Scilex Pharmaceuticals
  • Teva Pharmaceutical Industries Ltd.
  • Trevena Inc.

Table Information

Report AttributeDetails
No. of Pages181
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 8.87 Billion
Forecasted Market Value ( USD ) by 2032 $ 12.91 Billion
Compound Annual Growth Rate6.4%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Pain Management Therapeutics Market - Global Forecast 2026-2032 - Product Image

Pain Management Therapeutics Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Analgesics Market - Global Forecast 2026-2032 - Product Image

Analgesics Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Pain Management Drugs Market Overview, 2025-2030 - Product Image

Pain Management Drugs Market Overview, 2025-2030

  • Report
  • 138 Pages
  • Global
From
Cancer Pain Market - A Global and Regional Analysis: Focus on Drug Class, Distribution Channel, and Region - Analysis and Forecast, 2025-2035 - Product Image

Cancer Pain Market - A Global and Regional Analysis: Focus on Drug Class, Distribution Channel, and Region - Analysis and Forecast, 2025-2035

  • Report
  • Global
From
Pain Management Drugs Market Outlook, 2030 - Product Image

Pain Management Drugs Market Outlook, 2030

  • Report
  • 203 Pages
  • Global
From

About the Cancer Pain Management Market

The Cancer Pain Management market within the context of Palliative Care is focused on providing relief from the physical and psychological symptoms of cancer. This includes managing pain, fatigue, nausea, depression, anxiety, and other symptoms. Pain management strategies may include medications, physical therapy, psychological counseling, and other treatments. Palliative care also includes providing emotional and spiritual support to patients and their families. Companies in the Cancer Pain Management market include pharmaceutical companies, medical device manufacturers, and healthcare providers. Examples include Pfizer, Merck, Johnson & Johnson, Novartis, and AbbVie. Additionally, there are a number of specialized companies that focus on providing palliative care services, such as Hospice Care, Inc., and Comfort Care Hospice. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.